News

SEARCH FIRM NEWS

news November 12, 2019

Ivan Wasserman to Speak on Commercial and Legal Implications Taxonomic Changes to the Genus Lactobacillus

Join Ivan Wasserman as he discusses commercial and legal implications taxonomic changes to the genus lactobacillus. The webinar will take place December 11 at 12:30pm Eastern/9:30am Pacific. For more information click here.

news November 9, 2019

Jennifer Adams to Speak on Class Actions and “Need-to-Know” Strategies for Facing False Advertising Lawsuits

Class action lawsuits against dietary supplement and functional food companies continue to increase and present a significant legal risk to these industries. In the past, class actions tended to target egregious and outlandish claims, but more and more, many of these cases are challenging basic structure/function claims. Given this landscape, it is important for companies […]

news October 2, 2019

State hemp and CBD is still not easy to navigate

As FDA continues to contemplate potential regulatory pathways for hemp-derived CBD, an increasing number of states are moving forward with their own laws and policies aimed at regulating this popular product category, especially in the dietary supplement and food space. Several states are imposing robust testing, labeling and registration requirements for these products—with more likely […]

news October 1, 2019

Trump executive action will force change in FTC guidance process

The Federal Trade Commission will have to be more precise when issuing guidance documents, won’t be able to use them to circumvent the rulemaking process and can’t ask judges to defer to the guidance when issuing decisions. These changes are a result of an executive order signed by President Donald Trump Oct. 9 as part of his administration’s […]

news September 16, 2019

FTC eyes more aggressive action against CBD disease claims

While targeting claims that CBD treats serious diseases like cancer, the Federal Trade Commission has issued a few rounds of warning letters—including three this month. But in an interview with Natural Products INSIDER, an FTC official suggested the agency will take more forceful enforcement action in the future against marketers who advertise CBD as a […]

news June 6, 2019

Amin Talati Law Firm Announces Name Change; Plans to Continue Expansion in Core Areas

Leading regulatory and intellectual property law firm Amin Talati today announced that effective June 1, 2019, the firm’s name changed to Amin Talati Wasserman LLP, making Ivan Wasserman, who also serves as the firm’s managing partner, a name partner. “Our new name is a reflection of how far we have come and how far we […]

news February 6, 2019

Prominent Medical Device Attorney, Neil O’Flaherty, Joins Amin Talati in Washington, DC

Neil O’Flaherty has over 28 years of experience involving FDA regulation of medical devices and other products. He has spoken, written and advised extensively on medical device and other FDA-related topics, including the regulation of mobile medical apps and other medical software products, in vitro diagnostics (including genetic and other laboratory tests), human cells, tissues, and […]

news December 7, 2018

Amin Talati Bolsters Trademark Practice With Addition of Two IP Leaders

Ms. Roach’s practice focuses exclusively on the trademark lifecycle. Since 2006, she has counseled clients on brand selection, portfolio strategy, trademark application prosecution, brand enforcement and defense, anti-counterfeiting measures, and trademark maintenance stretching from the United States to more than 140 countries around the world. Her extensive knowledge of trademark law helps her clients secure […]

What's Now

FTC Issues Proposed Rule and Announces Possible Additional Rulemaking to Deter Deceptive Claims by Multi-Level Marketers

On January 13, 2025, the FTC issued a Notice of Proposed Rulemaking (NPRM) for a new Earnings Claim Rule Regarding Multi-Level Marketing (MLM).   In the NPRM, the FTC asserts that “[t]he vast majority of MLM MORE >

see all news >